NO20006479L - Tienopyridinforbindelser, deres fremstilling og anvendelse - Google Patents

Tienopyridinforbindelser, deres fremstilling og anvendelse

Info

Publication number
NO20006479L
NO20006479L NO20006479A NO20006479A NO20006479L NO 20006479 L NO20006479 L NO 20006479L NO 20006479 A NO20006479 A NO 20006479A NO 20006479 A NO20006479 A NO 20006479A NO 20006479 L NO20006479 L NO 20006479L
Authority
NO
Norway
Prior art keywords
tienopyridine
compounds
preparation
cancer
sex hormone
Prior art date
Application number
NO20006479A
Other languages
English (en)
Other versions
NO20006479D0 (no
Inventor
Shuichi Furuya
Nobuo Choh
Nobuhiro Suzuki
Takashi Imada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20006479L publication Critical patent/NO20006479L/no
Publication of NO20006479D0 publication Critical patent/NO20006479D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Forbindelsen ifølge foreliggende oppfinnelse har utmerket antagonistisk virkning overfor gonadotropin-frigjørende hormon og er nyttig til forebygging eller behandling av kjønnshormon-avhengige sykdommer, f.eks. kjønnshormon-avhengige krefttyper (f.eks. prostatakreft, livmorkreft, brystkreft, hypofysetumor), prostata-hypertrofi, hysteromyom, endometriose, brå-utviklet pubertet, amenoré-syndrom, multilokulært ovariesyndrom, kviser osv., eller som graviditetsregulator (f.eks. befhiktningshindrende middel), som middel mot ufruktbarhet eller som menstruasjonsregulerende middel.
NO20006479A 1998-06-26 2000-12-19 Tienopyridinforbindelser, deres fremstilling og anvendelse NO20006479D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18126398 1998-06-26
JP33300498 1998-11-24
PCT/JP1999/003379 WO2000000493A1 (en) 1998-06-26 1999-06-24 Thienopyridine compounds, their production and use

Publications (2)

Publication Number Publication Date
NO20006479L true NO20006479L (no) 2000-12-19
NO20006479D0 NO20006479D0 (no) 2000-12-19

Family

ID=27308836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006479A NO20006479D0 (no) 1998-06-26 2000-12-19 Tienopyridinforbindelser, deres fremstilling og anvendelse

Country Status (9)

Country Link
US (1) US6262267B1 (no)
EP (1) EP1090010A1 (no)
AU (1) AU4393199A (no)
BR (1) BR9911564A (no)
CA (1) CA2331399A1 (no)
HU (1) HUP0102805A3 (no)
NO (1) NO20006479D0 (no)
SK (1) SK19752000A3 (no)
WO (1) WO2000000493A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4066552B2 (ja) * 1999-03-16 2008-03-26 コニカミノルタビジネステクノロジーズ株式会社 画像形成装置
EP1291023A1 (en) * 2000-06-14 2003-03-12 Takeda Chemical Industries, Ltd. Sustained release compositions
AU2001288102A1 (en) * 2000-09-22 2002-04-02 Takeda Chemical Industries Ltd. Solid preparations
US7569570B2 (en) 2002-01-30 2009-08-04 Takeda Pharmaceutical Company Limited Thienopyrimidines, process for preparing the same and use thereof
EP1495768A4 (en) * 2002-04-12 2007-12-05 Takeda Pharmaceutical MEANS FOR THE PREVENTION / TREATMENT OF HITZEWALLUNGEN
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
ES2314444T3 (es) 2003-08-29 2009-03-16 Pfizer Inc. Tienopiridina-fenilacetaminasy sus derivados utiles como nuevos agentes antiangiogenicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
EP0781774B1 (en) 1995-12-08 2002-07-31 Takeda Chemical Industries, Ltd. Prolactin production inhibitory agents
ID17260A (id) 1996-04-26 1997-12-11 Takeda Chemical Industries Ltd Turunan tieno piridina dan produksi serta gunanya

Also Published As

Publication number Publication date
BR9911564A (pt) 2001-10-09
HUP0102805A3 (en) 2002-04-29
EP1090010A1 (en) 2001-04-11
HUP0102805A2 (hu) 2001-11-28
CA2331399A1 (en) 2000-01-06
AU4393199A (en) 2000-01-17
WO2000000493A1 (en) 2000-01-06
SK19752000A3 (sk) 2001-08-06
US6262267B1 (en) 2001-07-17
NO20006479D0 (no) 2000-12-19

Similar Documents

Publication Publication Date Title
CY1110009T1 (el) Συνθεσεις μικροδιαμερισμενης ταναπρογετης και μεθοδοι παρασκευης τους
NO20075849L (no) Fremgangsmater og preparater til behandling eller forebygging av kreft
ECSP066913A (es) Compuestos de difenil-ox-indol-2-ona y su uso en el tratamiento del cancer
TR200102577T2 (tr) Kanser Tedavisi için Casb616 Polipeptid ve Polinücleotidlerin kullanımı
NO20032759D0 (no) 2-fenylbenzimidazoler og imidazo-[4,5]-pyridiner som SDSI/CHK2-inhibitorerog adjuvanter ved kjemoterapi eller strålingsterapi ved behandlingav kreft
NO20006479L (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
WO2004058171A3 (en) Antibodies against gpr64 and uses thereof
DE602004028651D1 (de) Neutralisierbares epitop von hgf und an dieses bindende neutralisierender antikörper
CY1108462T1 (el) Χρηση της αναστροζολης για τη θεραπευτικη αντιμετωπιση μετεμμηνοπαυσιακων γυναικων με καρκινο του μαστου σε πρωιμο σταδιο
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
MXPA05011755A (es) Composiciones y metodos para inmunoterapia especifica de tumor wilms 1.
BG106738A (en) A method for chemoprevention of prostate cancer
CY1110017T1 (el) Μικρονισμενη ταναπρογετη και συνθεσεις που περιεχουν αυτην
TW200700082A (en) Therapy of prostate cancer with ctla4 antibodies and hormonal therapy
ECSP055574A (es) Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con hormonas.
CL2007002382A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel.
AU2003255820A8 (en) Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
AP2004002995A0 (en) Combination therapy for the treatment of cancer
AU2002357644A8 (en) Therapeutic agents and corresponding treatments
GB9920908D0 (en) Chalcone coumarins
ES2187796T3 (es) Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano.
EA200200943A1 (ru) Гормональная терапия рака молочной железы
PE20050665A1 (es) ESTROGENOS SELECTIVOS DE 8ß-VINIL-ESTRA-1,3,5(10)-TRIEN-3,17ß-DIOL Y 17ß-FLUOR-9-VINIL-ESTRA-1,3,6(10)-TRIEN-3,16ALFA-DIOL
TW430665B (en) Thienopyridine compounds for antagonizing gonadotropin-releasing hormone and their production
IL143988A0 (en) Compositions and methods for intraductal gene therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application